Stephanie Kohl
Stephanie Kohl
Chinese centralised intravenous admixture service (CIVAS), an emerging pharmaceutical industry: survey of the recent advances of CIVAS in China [0.03%]
中国集中配制中心(CIVAS)：新兴的制药行业——对中国近期CIVAS进展的调查研究
Wenjie Mi,Lin Li,Yan Zhang et al.
Wenjie Mi et al.
Purpose: To present the results of a survey involving 97 centralised intravenous admixture service (CIVAS) centres in China to review the recent advances of Chinese CIVAS. ...
Compatibility of proton pump inhibitors in a preservative-free suspending vehicle [0.03%]
无防腐剂悬浮媒介中的质子泵抑制剂的兼容性
Hudson C Polonini,Sharlene L Silva,Shirley Loures et al.
Hudson C Polonini et al.
Objectives: To evaluate the microbiological and physicochemical compatibility of commonly used proton pump inhibitors (PPIs) esomeprazole, lansoprazole, omeprazole and pantoprazole compounded at a single concentration usi...
Furosemide ethanol-free oral solutions for paediatric use: formulation, HPLC method and stability study [0.03%]
一种不含乙醇的儿童用呋塞米口服溶液：配制、HPLC方法及稳定性研究
Lukáš Zahálka,Sylva Klovrzová,Ludmila Matysová et al.
Lukáš Zahálka et al.
Background: Oral liquid solutions of the diuretic active ingredient furosemide (FUR) marketed across Europe do not comply with recent requirements for paediatric preparation owing to their ethanol content and, moreover, i...
Impact of fampridine on quality of life: clinical benefit in real-world practice [0.03%]
富马酸福米替尼对生活质量的影响：真实世界实践中的临床益处
María Belén Marzal-Alfaro,María Luisa Martín Barbero,JoseM García Domínguez et al.
María Belén Marzal-Alfaro et al.
Objectives: To assess the effectiveness and tolerability of fampridine in patients with multiple sclerosis (MS) in real clinical practice and to analyse adherence to treatment and general satisfaction of patients in terms...
Anaemia predictors in patients with chronic hepatitis C treated with ribavirin and direct-acting antiviral agents [0.03%]
利巴韦林及直接抗病毒药物治疗的慢性丙型肝炎患者的贫血预测因素
Emilio Molina-Cuadrado,Héctor Mateo-Carrrasco,Antonio Collado et al.
Emilio Molina-Cuadrado et al.
Objectives: Anaemia is the most common side effect associated with ribavirin (RBV). This study intended to assess its incidence and determine its predictive factors in patients with hepatitis C virus on RBV plus direct-ac...
Predictors of primary non-adherence to concomitant chronic treatment in HIV-infected patients with antiretroviral therapy [0.03%]
抗逆转录病毒治疗患者的HIV合并慢性疾病初次原发不依从性的预测因素分析
Yolanda Borrego,Encarnación Gómez-Fernández,Rocío Jiménez et al.
Yolanda Borrego et al.
Objectives: To identify the independent risk factors of primary non-adherence to chronic concomitant treatment in HIV-positive patients, and to measure primary and secondary non-adherence rates to chronic treatments, and ...
Individualised antimicrobial dosing in critically ill patients undergoing continuous renal replacement therapy: focus on total drug clearance [0.03%]
连续肾脏替代治疗下危重症患者抗菌药物个体化剂量调整的重点是全身药物清除率的评估
Jesus Ruiz,Cassandra Favieres,Maria Jesús Broch et al.
Jesus Ruiz et al.
Background: Continuous renal replacement therapy (CRRT) is common practice in critical care patients with acute renal failure. Objectives: ...
QTc prolongation during erythromycin used as prokinetic agent in ICU patients [0.03%]
重症监护病房患者使用红霉素作为促动力药物时的QTc间期延长
R B Fiets,J M Bos,Art Donders et al.
R B Fiets et al.
Background: High-dose erythromycin used as antibiotic prolongs QTc interval. Low-dose erythromycin is frequently used as a prokinetic agent, especially in patients in the intensive care unit (ICU). It is unknown whether l...